Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Update on ConXn clinical progress

May 24, 1996

COX-2 inhibitors in clinical trials at Merck & Co.

May 24, 1996

COX-2 inhibitor selected for further study at Searle

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

SmithKline Beecham's C-DART approach to rheumatoid arthritis

May 17, 1996

Novel antiarthritics claimed by Procter & Gamble

May 17, 1996

British Biotech reveals metalloproteinase inhibitors

May 17, 1996

COX-2 inhibitors claimed by Searle

May 17, 1996

Hoechst claims treatment for chronic polyarthritis

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...